Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema

AIMS: To determine the feasibility, safety, and clinical efficacy of intravitreal 0.7-mg dexamethasone implants (Ozurdex) in patients with refractory cystoid macular edema after uncomplicated cataract surgery. METHODS AND MATERIALS: In this study, 11 eyes of 11 patients affected by pseudophakic cyst...

Descripción completa

Detalles Bibliográficos
Autor principal: Al Zamil, Waseem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398816/
https://www.ncbi.nlm.nih.gov/pubmed/25892932
http://dx.doi.org/10.1016/j.sjopt.2014.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398816/
https://www.ncbi.nlm.nih.gov/pubmed/25892932
http://dx.doi.org/10.1016/j.sjopt.2014.10.005

Ejemplares similares